Showing 11,901 - 11,920 results of 104,446 for search '(( 100 d decrease ) OR ( 5 ((teer decrease) OR (((a decrease) OR (mean decrease)))) ))', query time: 1.82s Refine Results
  1. 11901
  2. 11902
  3. 11903

    Flow chart describing the literature search. by Yu Xiong (1478806)

    Published 2023
    “…</p><p>Results</p><p>Twenty-five randomized controlled trials were included. …”
  4. 11904
  5. 11905
  6. 11906

    Punicalagin ameliorates lipopolysaccharide-induced inflammatory response in dental pulp cells via inhibition of the NF-κB/Wnt5a-ROR2 pathway by Yumeng Yang (8155002)

    Published 2025
    “…</p> <p>PCG demonstrated an anti-inflammatory effect in LPS-induced DPCs by targeting the NF-κB/Wnt5a-ROR2 signaling pathway.</p> <p></p> <p>This schematic illustration demonstrates that PCG ameliorates LPS-elicited pulpitis by decreasing the expression of the proteins associated with the NF-κB signaling pathway and its downstream Wnt5a/ROR2 pathway and by reducing the production of inflammatory molecules.…”
  7. 11907
  8. 11908

    3’UTR luciferase assay and Western blotting identify Integrin alpha V and N-WASP as relevant regulatory targets of miR-142-3p. by Alexander Schwickert (835514)

    Published 2015
    “…The migration position of molecular weight markers relative to Integrin-αV and N-WASP is shown in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0143993#pone.0143993.s004" target="_blank">S4 Fig</a>.…”
  9. 11909

    Association of Matrix Metalloproteinase-3 -1171(5A>6A) Polymorphism with Cancer Risk: A Meta-Analysis of 41 Studies by Xin Yang (104842)

    Published 2014
    “…</p><p>Conclusion</p><p>This meta-analysis suggests that the -1171(5A>6A) polymorphism in MMP3 promoter region is not associated with overall cancer risk, but it may contribute to decreased cancer risk in Asian population when compared with Caucasian population and significantly reduce the risk of gastrointestinal cancer.…”
  10. 11910
  11. 11911

    table5_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  12. 11912
  13. 11913
  14. 11914
  15. 11915
  16. 11916
  17. 11917

    LGI1 Abs decrease the expression of AMPA-R inside clusters at the surface of excitatory neurons in the hippocampus. by Elodie Fels (13272457)

    Published 2022
    “…The total density of surface GluA1 subunits decreased after LGI1 P1 IgG infusion compared to control C1 IgG infusion in GAD- area in the DG of the hippocampus (Unpaired t test *p = 0.031, n<sub>Ctrl =</sub> 16 area, n<sub>LGI1</sub> = 13 area) (B) but not in CA3 region (Mann-Whitney test p = 0.33, n<sub>Ctrl =</sub> 19 area, n<sub>LGI1</sub> = 9 area) (C) nor CA1 (Unpaired t-test p = 0.49, n<sub>Ctrl =</sub> 11 area, n<sub>LGI1</sub> = 14 area) (D). …”
  18. 11918

    Table_1_Atypical neurological manifestations in anti-IgLON5 disease: a case report.docx by Yun Chen (279569)

    Published 2024
    “…<p>Anti-IgLON5 disease is a recently discovered autoimmune encephalopathy with sleep disorder as a hallmark in the majority of reported cases. …”
  19. 11919
  20. 11920